{
    "clinical_study": {
        "@rank": "144423", 
        "acronym": "LL-PTC", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate Leptin levels in females, in the setting of\n      papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid\n      disease."
        }, 
        "brief_title": "Leptin Levels in Papillary Thyroid Cancer", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Thyroid Cancer, Papillary", 
            "Leptin Levels"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Thyroid Neoplasms", 
                "Thyroid Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "There will be three groups in this study, but 2 of the groups are part of another study so\n      will only recruit normal controls."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female\n\n          -  Age>/- 19\n\n          -  Not currently pregnant or lactating\n\n          -  Normal thyroid gland by history\n\n        Exclusion Criteria:\n\n          -  Male Gender\n\n          -  Pregnancy\n\n          -  Lactation\n\n          -  Age below 19\n\n          -  Abnormal thyroid gland by history\n\n          -  Abnormal thyroid gland by structure using ultrasound\n\n          -  Abnormal thyroid gland by function using TSH, Free T4"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "19 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Females with no prior history of thyroid disease and not on thyroid medications.\n\n        Active recruitment will be for normal controls only. They will be age and weight/height\n        matched to females with prior diagnosis of thyroid cancer or thyroid nodules who are\n        already part of another study."
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01659385", 
            "org_study_id": "276-12-EP"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Omaha", 
                    "country": "United States", 
                    "state": "Nebraska", 
                    "zip": "68198"
                }, 
                "name": "University of Nebraska Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls", 
        "overall_official": {
            "affiliation": "University of Nebraska", 
            "last_name": "Whitney Goldner, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.", 
            "measure": "evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.", 
            "safety_issue": "No", 
            "time_frame": "During Study"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01659385"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Nebraska", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Nebraska", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}